<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04944641</url>
  </required_header>
  <id_info>
    <org_study_id>2013-032</org_study_id>
    <nct_id>NCT04944641</nct_id>
  </id_info>
  <brief_title>Epilepsy Prevalence and Intervention Study in Zhejiang Province, China</brief_title>
  <official_title>Epilepsy Prevalence and Intervention Study in Zhejiang Province, China</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Second Affiliated Hospital, School of Medicine, Zhejiang University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hangzhou Center of Disease Control and Prevention</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Central Hospital of Lishui City</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>the second hospital of Jiaxing city</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shengzhou People's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Children's Hospital Affiliated to Zhejiang University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Second Affiliated Hospital, School of Medicine, Zhejiang University</source>
  <brief_summary>
    <textblock>
      To carry out the epidemiological investigation on epilepsy in Zhejiang Province, China, and&#xD;
      then establish early comprehensive intervention to help patients with epilepsy to improve&#xD;
      seizure control and the quality of life.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To carry out the epidemiological investigation on epilepsy in Zhejiang Province, China, and&#xD;
      then establish early comprehensive intervention（proper antiepileptic drugs and education&#xD;
      intervention） to help patients with epilepsy to improve seizure control and the quality of&#xD;
      life.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 13, 2013</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>randomly group into two</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline seizures frequency 1</measure>
    <time_frame>12 months</time_frame>
    <description>change from baseline seizures frequency at 12 months, seizure frequency is defined as the number of seizure attacks during 3 months before baseline or endpoint)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline seizures frequency 2</measure>
    <time_frame>24 months</time_frame>
    <description>change from baseline seizures frequency at 24 months, seizure frequency is defined as the number of seizure attacks during 3 months before baseline or endpoint)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Occurrence of refractory epilepsy</measure>
    <time_frame>24 months</time_frame>
    <description>occurrence of refractory epilepsy at 24 months</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of life (QOL scales)</measure>
    <time_frame>2 year</time_frame>
    <description>Quality of Life Scale, high scores mean a better outcome</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Epilepsy</condition>
  <arm_group>
    <arm_group_label>A: Routine AED group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Routine and proper antiepileptic drugs group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B: AED and education group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Routine, proper antiepileptic drugs and education group</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>education on epilepsy</intervention_name>
    <description>education on epilepsy, including epilepsy diary, pamphlet，discussion between patients and phone visits and so on</description>
    <arm_group_label>B: AED and education group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>routine and proper antiepileptic drugs</intervention_name>
    <description>routine and proper antiepileptic drugs</description>
    <arm_group_label>A: Routine AED group</arm_group_label>
    <arm_group_label>B: AED and education group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Newly diagnosed and untreated epilepsy; Aged 14 and above; Sign the informed consents.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        With intellectual development disorder; With serious heart and lung diseases.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>14 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Mei-ping Ding</last_name>
    <phone>13588058581</phone>
    <email>dmp-neurology@zju.edu.cn</email>
  </overall_contact>
  <location>
    <facility>
      <name>2nd Affiliated Hospital, School of Medicine, Zhejiang University, China</name>
      <address>
        <city>Hangzhou</city>
        <state>Zhejiang</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mei-ping Ding</last_name>
      <phone>13588058581</phone>
      <email>dmp-neurology@zju.edu.cn</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Shengzhou People's Hospital</name>
      <address>
        <city>Shengzhou</city>
        <country>China</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>June 8, 2021</study_first_submitted>
  <study_first_submitted_qc>June 21, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 29, 2021</study_first_posted>
  <last_update_submitted>July 13, 2021</last_update_submitted>
  <last_update_submitted_qc>July 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>epilepsy prevalence, intervention</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Epilepsy</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anticonvulsants</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

